Updated efficacy and safety of larotrectinib in patients with TRK fusion salivary gland tumours Meeting Abstract


Authors: Hong, D. S.; Tahara, M.; Baik, C.; Bauman, J. R.; Gilbert, J.; Brose, M. S.; Grilley-Olson, J. E.; Patil, T.; McDermott, R.; Raez, L. E.; Johnson, J. M.; Shen, L.; Norenberg, R.; Dima, L.; Mussi, C.; Le, X.; Drilon, A. E.
Abstract Title: Updated efficacy and safety of larotrectinib in patients with TRK fusion salivary gland tumours
Meeting Title: ESMO Congress 2022
Journal Title: Annals of Oncology
Volume: 33
Issue: Suppl. 7
Meeting Dates: 2022 Sep 9-13
Meeting Location: Paris, France
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2022-09-01
Start Page: S847
End Page: S848
Language: English
ACCESSION: WOS:000866211600658
DOI: 10.1016/j.annonc.2022.07.791
PROVIDER: wos
Notes: Meeting Abstract: 667P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon